- Revenue 2024
- $504,858
- Expenses 2024
- $2,591,563
Program services were 69.7% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
As filed
- Subsection
- 03
- NTEE code
- E120
- Classification
- 1000
- Street
- 2101 4TH AVE STE 1950
These codes are the IRS's own and are shown exactly as filed. What each one means is in the Business Master File documentation (opens in a new tab).
Mission and programs · 2024
Mission
BVGH drives sustainable, market-informed solutions to improve access to quality healthcare in low- and middle-income countries. BVGH builds cross-sector partnerships that align industry, government, and local health-system priorities to expand access to cancer care, infectious disease technologies, and essential medicines. BVGHs flagship programs focus on strengthening cancer and infectious disease ecosystems through coordinated national strategies, capacity building, and responsible product introduction. Key activities include the African Access Initiative (AAI), which supports countries in developing cancer control plans, expanding diagnostics and treatment capacity, and improving affordability and availability of oncology products. BVGH also brokers collaborations between companies and African research institutions to advance R&D, clinical trials, workforce training, and technology transfer. These activities collectively enhance health-system readiness, accelerate access to lifesavi
Activities or mission (Part I)
BVGH builds partnerships to expand access to healthcare in LMICs, by strengthening health systems, coordinating national planning, building capacity, and managing procurement. Its work aligns and informs government and industry strategies and policies.
-
African Access Initiative (AAI): A PPP that targets the cancer crisis in Africa. Through AAI, BVGH is strengthening healthcare systems, building oncology capacity and skills, forging research and development partnerships led by African healthcare professionals, building and promoting clinical trial readiness, and creating community awareness and promoting health education. AAI has trained more than 18,000 oncology healthcare professionals, delivered access to multiple cancer medicines, and forged countless partnerships.
Expenses $1,631,966
-
BVGH Other Programs: BVGH develops and manages programs that advance LMIC government objectives as they relate to: public-private partnership development; strategic and implementation planning development; program implementation and management; and international partner program management (across research, health systems strengthening, workforce development, and climate and agriculture as they intersect with health). BVGH develops market assessment and entry reports for the private sector to inform short and long-term investments and decision making. Market reports include: economic and country stability and risk assessment; country SWOT analysis; market and growth potential; regulatory and payor systems analysis; innovative financing opportunities; stakeholder mapping; and more. Other programs include: laboratory and medtech systems placement, delivery, and training.
Expenses $87,204
-
BVGH Infectious Disease Programs (Global Innovation Alliance (GIA) and Global Innovation Alliance Network of Trial Sites (GIANTS)): BVGH catalyzes and manages global cross-organization, cross-sector collaborations to advance research and development (R&D) targeting infectious diseases with high burdens in LMICs. Through the Global Innovation Alliance (GIA), BVGH: 1.) builds and manages R&D collaborations between LMIC scientists and global partners; 2.) assesses, promotes, and fosters clinical trial capacity and inclusion in LMICs; 3.) elevates scientific expertise in LMICs through tailored capacity building programs; and 4.) evaluates and communicates program outcomes and impacts to broad and targeted global audiences. The programs strengthen laboratory capacity, support technology transfer, and advance co-developed R&D initiatives for vaccines, therapeutics, and diagnostics. By integrating country-level health system knowledge with real-world implementation data, BVGH helps partners accelerate innovation and prepare for feasible adoption pathways. This work contributes to more resilient infectious disease response systems and informed policy decision-making.
Expenses $86,143
As filed on the 2024 return.
Officers and directors · 2024
As listed in Part VII of the 2024 return, in the order the filer printed them. Each return names its own; this is not a roster the organization keeps with us.
-
Jennifer Dent
President & CEO
- Total calculated
- $486,109
- From this org
- $433,705
- From related orgs
- $0
- Other
- $52,404
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $343,705
- Bonus
- $90,000
- Other
- not reported
- Deferred
- $17,248
- Nontaxable benefits
- $35,156
- Filer's total
- $486,109
-
Katy Graef
Vice President Programs
- Total calculated
- $208,226
- From this org
- $190,233
- From related orgs
- $0
- Other
- $17,993
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $190,233
- Bonus
- not reported
- Other
- not reported
- Deferred
- $9,512
- Nontaxable benefits
- $8,481
- Filer's total
- $208,226
-
Cathyryne Manner
Vice President
- Total calculated
- $188,815
- From this org
- $170,208
- From related orgs
- $0
- Other
- $18,607
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $170,208
- Bonus
- not reported
- Other
- not reported
- Deferred
- $7,798
- Nontaxable benefits
- $10,809
- Filer's total
- $188,815
-
Jim Geraghty
Chair
- Total calculated
- $0
- Hours/week
- 2
-
Rachel King
Director
- Total calculated
- $0
- Hours/week
- 1
-
Ruth Atherton
Director
- Total calculated
- $0
- Hours/week
- 1
-
Belinda Termeer
Director
- Total calculated
- $0
- Hours/week
- 1
-
Dr Julie Gralow
Director
- Total calculated
- $0
- Hours/week
- 1
-
Seringe Magueye Gueye
Director
- Total calculated
- $0
- Hours/week
- 1
-
J Leighton Read MD
Director
- Total calculated
- $0
- Hours/week
- 1
-
John Nevergole
Director
- Total calculated
- $0
- Hours/week
- 2
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us. Earlier years are each on their own filing page.
Filings
-
2024
- Revenue
- $504,858
- Expenses
- $2,591,563
- Contributions
- $504,858
- Grants paid
- $0
-
2023
- Revenue
- $4,702,895
- Expenses
- $2,437,035
- Contributions
- $4,702,893
- Grants paid
- $0
-
2022
- Revenue
- $1,971,687
- Expenses
- $2,227,074
- Contributions
- $1,971,618
- Grants paid
- $58,320
The four totals the IRS asks for on Part I of the Form 990, as filed. A dash means the figure was not present on the return — not that it was zero.
Other returns filed
-
2021 · 990
- Revenue
- $3,211,056
- Expenses
- $2,124,020
- Assets (EOY)
- $5,318,274
-
2020 · 990
- Revenue
- $4,396,021
- Expenses
- $1,662,747
- Assets (EOY)
- $4,194,099
-
2019 · 990
- Revenue
- $1,637,421
- Expenses
- $1,841,899
- Assets (EOY)
- $1,454,032
-
2019 · 990
- Revenue
- $2,120,671
- Expenses
- $1,834,552
- Assets (EOY)
- $1,415,465
-
2017 · 990
- Revenue
- $2,135,139
- Expenses
- $1,943,256
- Assets (EOY)
- $1,361,784
-
2016 · 990
- Revenue
- $1,728,998
- Expenses
- $1,867,508
- Assets (EOY)
- $1,165,063
-
2015 · 990
- Revenue
- $1,766,106
- Expenses
- $1,560,942
- Assets (EOY)
- $1,284,313
-
2014 · 990
- Revenue
- $1,189,276
- Expenses
- $1,171,175
- Assets (EOY)
- $1,073,183
-
2013 · 990
- Revenue
- $927,738
- Expenses
- $705,081
- Assets (EOY)
- $1,135,981
-
2012 · 990
- Revenue
- not reported
- Expenses
- $3,249,906
- Assets (EOY)
- $1,242,760
Nonprofiteer parses Forms 990, 990-EZ and 990-PF, in a window of recent tax years. These returns are recorded from the IRS e-file index, so their figures were extracted by that index rather than read from the return here — treat them as a different source from the filings above, not as more of the same record. A dash means the index carries no figure; Form 990-T listings carry none at all. Showing the 10 most recent; the API carries the rest.
Grants made
No itemized grants to organizations. Schedule I is filed only by organizations that granted more than $5,000 to a recipient, so most filers have none.
Grants received
-
2023 CONTRIBUTION
-
2024 HEALTH
Other IRS files
Auto-Revocation List
Not listed. The IRS publishes this list for organizations whose exemption was automatically revoked for failing to file for three consecutive years.
Publication 78
Listed as of 13 October 2026, under deductibility PC.
These are two separate IRS files on two separate schedules, shown as published and not reconciled with each other. Neither is a statement about whether a contribution is deductible today: 19,245 organizations appear in Publication 78 while the IRS's own revocation file lists them as currently revoked, more than half of those revoked before 2019. Absence from Publication 78 is evidence of nothing, and presence is not evidence either. Verify current status with the IRS before relying on it.
What this page reflects
The registration facts above come from the IRS Business Master File published 13 October 2026 and read 1 November 2026, for every organization at once. Returns through tax year 2024, the newest we have parsed for this organization.